(Q36836174)

English

Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer

scientific article published on December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

based on heuristic

inferred from title

author name string

Mark S Tichenor

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

John D Trzupek

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

David B Kastrinsky

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Futoshi Shiga

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Inkyu Hwang

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Dale L Boger

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

1 December 2006

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Journal of the American Chemical Society

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

128

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

49

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

15683-15696

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sequence-selective DNA recognition: natural products and nature's lessons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

29 September 2017

Mechanisms of in situ activation for DNA-targeting antitumor agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

29 September 2017

Synthesis and antiviral evaluation of trisubstituted indole N-nucleosides as analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole (TCRB).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

29 September 2017

Crystal structure of the nucleosome core particle at 2.8 A resolution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

29 September 2017

CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

29 September 2017

Duocarmycin A, a new antitumor antibiotic from Streptomyces

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

29 September 2017

Mechanism of interaction of CC-1065 (NSC 298223) with DNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

27 June 2018

Alkylation of duplex DNA in nucleosome core particles by duocarmycin SA and yatakemycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

5 September 2018

Total synthesis, structure revision, and absolute configuration of (+)-yatakemycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

5 September 2018

Establishing the parabolic relationship between reactivity and activity for derivatives and analogues of the duocarmycin and CC-1065 alkylation subunits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

5 September 2018

DNA alkylation properties of yatakemycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

5 September 2018

Total synthesis of the duocarmycins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

5 September 2018

Yatakemycin, a novel antifungal antibiotic produced by Streptomyces sp. TP-A0356.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

5 September 2018

DNA interstrand cross-links induced by the cyclopropylpyrroloindole antitumor agent bizelesin are reversible upon exposure to alkali

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

5 September 2018

Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

5 September 2018

Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515590

5 September 2018

CC-1065 and the Duocarmycins: Synthetic Studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New synthetic method for indole-2-carboxylate and its application to the total synthesis of duocarmycin SA

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversibility of the covalent reaction of CC-1065 and analogues with DNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total synthesis of (+)-yatakemycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duocarmycin SA, a new antitumor antibiotic from Streptomyces sp

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An alternative and convenient strategy for generation of substantial quantities of singly 5'-32P-end-labeled double-stranded DNA for binding studies: development of a protocol for examination of functional features of (+)-CC-1065 and the duocarmycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular basis for sequence-specific DNA alkylation by CC-1065

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design, synthesis, and testing of potential antisickling agents. 5. Disubstituted benzoic acids designed for the donor site and proline salicylates designed for the acceptor site

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CC-1065 (NSC 298223), a novel antitumor agent that interacts strongly with double-stranded DNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CC-1065 (NSC 298223), a potent new antitumor agent improved production and isolation, characterization and antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Catalysis of the CC-1065 and duocarmycin DNA alkylation reaction: DNA binding induced conformational change in the agent results in activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17147378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yatakemycin, a Novel Antifungal Antibiotic Produced by Streptomyces sp. TP-A0356.

1 reference

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.56.107

12 April 2024

Duocarmycin A, a new antitumor antibiotic from Streptomyces.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1915

Identifiers

10.1021/JA064228J

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36836174&oldid=2127477506"